KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Bionano Genomics (BNGO) Interest Expenses (2017 - 2024)

Bionano Genomics (BNGO) has disclosed Interest Expenses for 8 consecutive years, with $122000.0 as the latest value for Q1 2024.

  • Quarterly Interest Expenses rose 60.53% to $122000.0 in Q1 2024 from the year-ago period, while the trailing twelve-month figure was $122000.0 through Dec 2024, down 97.62% year-over-year, with the annual reading at $5.1 million for FY2023, 1617.79% up from the prior year.
  • Interest Expenses hit $122000.0 in Q1 2024 for Bionano Genomics, down from $4.9 million in the prior quarter.
  • In the past five years, Interest Expenses ranged from a high of $4.9 million in Q4 2023 to a low of $2000.0 in Q3 2021.
  • Historically, Interest Expenses has averaged $528411.8 across 5 years, with a median of $77000.0 in 2022.
  • Biggest five-year swings in Interest Expenses: plummeted 99.66% in 2021 and later skyrocketed 6430.67% in 2023.
  • Year by year, Interest Expenses stood at $608000.0 in 2020, then tumbled by 91.12% to $54000.0 in 2021, then surged by 38.89% to $75000.0 in 2022, then surged by 6430.67% to $4.9 million in 2023, then tumbled by 97.51% to $122000.0 in 2024.
  • Business Quant data shows Interest Expenses for BNGO at $122000.0 in Q1 2024, $4.9 million in Q4 2023, and $71000.0 in Q3 2023.